DIABETE TYPE 2
Clinical trials for DIABETE TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new DIABETE TYPE 2 trials appear
Sign up with your email to follow new studies for DIABETE TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug also mend hearts? new study in kazakhstan investigates
Disease control OngoingThis study tests a dual GIP/GLP-1 drug (a type of diabetes medication) in 120 adults in Kazakhstan who have both chronic heart failure and type 2 diabetes. Participants take the drug for 40 weeks and have regular heart tests, blood work, and genetic checks. The goal is to see if …
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Nazarbayev University • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Diabetes drug shows promise for liver cirrhosis fluid
Disease control OngoingThis study looks at whether a type of diabetes medication called SGLT-2 inhibitors can help control ascites (fluid buildup in the belly) in people with liver cirrhosis and type 2 diabetes. About 40 adults will either receive the drug plus standard care or standard care alone for …
Matched conditions: DIABETE TYPE 2
Sponsor: University of Palermo • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
Blood test breakthrough could end painful liver biopsies for NASH patients
Diagnosis OngoingThis study looks at whether two blood markers, PLIN2 and RAB14, can accurately diagnose NASH (a serious liver disease) and advanced scarring, without needing a liver biopsy. Researchers will test these markers in 828 adults with NASH, type 2 diabetes, or obesity. If successful, t…
Matched conditions: DIABETE TYPE 2
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 12, 2026 12:05 UTC
-
Tiny sensor may spot hidden diabetes risk from common steroids
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 250 adults who are starting steroid treatment for conditions like autoimmune disease or inflammation. Researchers will use a continuous glucose monitor (CGM) for 14 days to see if it can detect early signs of steroid-induced diabetes better than standard tests…
Matched conditions: DIABETE TYPE 2
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:08 UTC
-
Diabetes mystery: why some escape complications while others suffer
Knowledge-focused OngoingThis observational study looks at 1,000 people with type 2 diabetes to understand why some develop serious complications like eye, kidney, or heart problems while others do not, even with similar blood sugar levels. Researchers will create a risk score and test blood samples for …
Matched conditions: DIABETE TYPE 2
Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC